<DOC>
	<DOCNO>NCT01193166</DOCNO>
	<brief_summary>The study ass use paliperidone palmitate compare oral antipsychotic treatment delay time protocol-defined treatment failure 12 month , patient diagnose schizophrenia recently release inpatient psychiatric hospital .</brief_summary>
	<brief_title>Twelve Month Study Comparing Paliperidone Palmitate Select Oral Antipsychotics Adults With Schizophrenia Who Have Been Recently Discharged From Inpatient Psychiatric Hospital</brief_title>
	<detailed_description>The primary objective study compare paliperidone palmitate treatment randomly assign oral antipsychotic treatment delay time treatment failure 12 month subject diagnose schizophrenia recently discharge inpatient psychiatric hospital . Patients receive either paliperidone palmitate 78 , 117 , 156 , 234 mg monthly injection twelve month OR oral aripiprazole , haloperidol , olanzapine , paliperidone , perphenazine , quetiapine , risperidone dos select study doctor .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Perphenazine</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Must able understand sign inform consent form approve Institutional Review Board ( IRB ) Must outpatient , follow acute exacerbation schizophrenia , discharge inpatient psychiatric hospital within 60 day screen Have current diagnosis schizophrenia Have available designate individual likely knowledge subject 's health status agree let study site personnel know change patient 's circumstance Women must postmenopausal ( least 2 year ) , surgically sterile ( hysterectomy bilateral oophorectomy , tubal ligation , otherwise incapable pregnancy ) , abstinent , sexually active , practice highly effective method birth control Allergies , hypersensitivity ( anaphylaxistype reaction ) , intolerance risperidone paliperidone Actively abuse intravenous drug Have positive urine drug screen test barbiturate , cocaine , amphetamine , opiates screen unstable medical illness Women pregnant breastfeeding , plan become pregnant Have receive injectable antipsychotic treatment within 2 injection cycle prior screen Received treatment clozapine within 3 month screen Attempted suicide within 6 month screen imminent risk suicide violent behavior , clinically assess investigator time screen homeless time stuyd consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Risperidone</keyword>
	<keyword>Risperdal</keyword>
	<keyword>Paliperidone palmitate</keyword>
	<keyword>Aripiprazole</keyword>
	<keyword>Haloperidol</keyword>
	<keyword>Olanzapine</keyword>
	<keyword>Paliperidone</keyword>
	<keyword>Perphenazine</keyword>
	<keyword>Quetiapine</keyword>
</DOC>